Ugro Capital witnesses strong momentum; disbursals back to pre-COVID level
Ugro Capital witnesses strong momentum; disbursals back to pre-COVID level
In Q3FY21, its cumulative disbursements went beyond Rs 2,000 crore. In the same quarter, the value of AUM stood at Rs 1,127 crore, which is a 15 per cent increase over its previous quarter.
This small-cap stock rallied 56 per cent in last 3 months!
Industrial biotechnology company, Praj Industries Ltd announced on Tuesday that it has bagged a prestigious breakthrough order to set up compressed biogas (CBG) project from Hindustan Petroleum Corporation Limited (HPCL).
PSP Projects Ltd rises on receiving new orders
The Ahmedabad-based company informed the bourses that it has received a letter of acceptance (LoA) amounting to Rs 1,491.34 crore (exclusive of GST) to construct medical colleges and hospitals at multiple locations in Uttar Pradesh.
Natco Pharma gains as its marketing partner get USFDA nod to market breast cancer drugs
The company’s marketing partner BPI will launch Everolimus tablets in the strengths of 2.5 mg, 5 mg, and 7.5 mg in the near term.
ISGEC zooms over 4 per cent on setting up world largest waste heat recovery boilers for Shree Cement
The company received the order for waste heat recovery boilers from the cement industry while its capacity makes it the largest in the world.
RailTel Corporation of India wins order worth Rs 25.46 crore
The company has received the order from Bharat Sanchar Nigam Limited (BSNL) for the commissioning of point-to-point links.
Adani Ports jumps over 2 per cent on acquiring 31.5 per cent stake in GPL
This is a strategic acquisition as the location of GPL in the north of Andhra Pradesh complements the company’s recent acquisition of the Port of Krishnapatnam that serves the south of AP.
Godrej Properties hits new 52-week high on emerging as highest bidder for 2 plots in Navi Mumbai
The company announced the addition of two residential plots in Sanpada (Navi Mumbai) from City & Industrial Development Corporation (CIDCO).
Biocon gains on approval to market Abevmy
The subsidiary of Biocon Ltd i.e. Biocon Biologics announced on Monday that it has received CHMP approval to market Abevmy, which is a biosimilar to Avastin.
Nava Bharat Ventures climbs over 4 per cent on buyback of shares
The company has approved the proposal for the buyback of fully paid-up equity shares for an aggregate amount, not exceeding Rs 150 crore, which is 5.05 per cent of the total paid-up equity share capital.
Zydus Cadila rises on receiving final approval from USFDA to market antidepressant drug
The drug may help improve mood and feelings of well-being, relieve anxiety and tension as well as increase energy level.
Granules India rises on USFDA approval for migraine drug
The drug will be manufactured in the company’s Hyderabad facility, which is expected to be launched in the near term.